A Fluorogenic Probe for Granzyme B Enables In-Biopsy Evaluation and Screening of Response to Anticancer Immunotherapies

Scientists reported the rational design of a fluorogenic peptide able to detect picomolar concentrations of active granzyme B as a biomarker of immune-mediated anticancer action.